0001140361-23-006075.txt : 20230210
0001140361-23-006075.hdr.sgml : 20230210
20230210184042
ACCESSION NUMBER: 0001140361-23-006075
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230208
FILED AS OF DATE: 20230210
DATE AS OF CHANGE: 20230210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Siurek Ryan H
CENTRAL INDEX KEY: 0001476512
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39659
FILM NUMBER: 23614015
MAIL ADDRESS:
STREET 1: 6200 SPRINT PARKWAY
CITY: OVERLAND PARK
STATE: KS
ZIP: 66251
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIODESIX INC
CENTRAL INDEX KEY: 0001439725
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 203986492
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2970 WILDERNESS PLACE
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 303-417-0500
MAIL ADDRESS:
STREET 1: 2970 WILDERNESS PLACE
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
4
1
form4.xml
X0306
4
2023-02-08
0001439725
BIODESIX INC
BDSX
0001476512
Siurek Ryan H
2970 WILDERNESS PLACE
SUITE 100
BOULDER
CO
80301
true
Chief Accounting Officer
Common Stock
2023-02-08
4
M
0
5483
A
29177
D
Common Stock
2023-02-09
4
S
0
2016
1.7991
D
27161
D
Restricted Stock Units
2023-02-08
4
A
0
82031
0
A
Common Stock
82031
82031
D
Restricted Stock Units
2023-02-08
4
M
0
1927
0
D
Common Stock
1927
23120
D
Restricted Stock Units
2023-02-08
4
M
0
3556
0
D
Common Stock
3556
7114
D
Each restricted stock unit (the "RSU") represents a contingent right to receive one share of Issuer's common stock.
These shares of Issuer's common stock were sold automatically to cover taxes upon the vesting of RSUs.
The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.71 to $1.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
These RSUs vest in a series of six successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
/s/ Robin H. Cowie as Attorney-in-Fact for Ryan H. Siurek
2023-02-10